JP Morgan Chase’s NanoViricides NNVC Stock Holding History
Bought
Maintained
Sold
Other funds holding NNVC
CCM
MFS
JP Morgan Chase's NNVC Position: Q2 2026 in Review
JP Morgan Chase held its NanoViricides (NNVC) position steady in Q2 2026 at 3,000 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #7099.
JP Morgan Chase first reported a position in NNVC in Q1 2014 and has held it in 19 quarters since. The position peaked at $72K in Q1 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.
- JP Morgan Chase held 3,000 shares of NanoViricides worth $4.11K as of Q2 2026.
- JP Morgan Chase left its NanoViricides share count unchanged in Q2 2026.
- NanoViricides made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7099 holding.
- JP Morgan Chase first reported a position in NanoViricides in Q1 2014 and has held it in 19 quarters since.
- JP Morgan Chase's NanoViricides position peaked at $72K in Q1 2014.
- 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.